LumiraDX Ltd.
(NASDAQ : LMDX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -2.17%567.741.0%$888.34m
DHRDanaher Corp. -2.47%273.520.7%$744.71m
ABTAbbott Laboratories -2.67%122.470.8%$683.30m
MDTMedtronic Plc -2.08%103.410.6%$648.88m
ISRGIntuitive Surgical, Inc. -0.10%269.260.8%$483.60m
ALGNAlign Technology, Inc. 0.56%465.366.4%$358.99m
DXCMDexCom, Inc. -0.17%421.407.8%$343.43m
SYKStryker Corp. -2.30%248.831.3%$315.78m
BSXBoston Scientific Corp. -1.75%42.221.0%$306.00m
BDXBecton, Dickinson & Co. -3.07%256.521.0%$294.09m
AAgilent Technologies, Inc. -0.83%136.371.6%$227.07m
EWEdwards Lifesciences Corp. -3.38%108.850.4%$212.44m
IDXXIDEXX Laboratories, Inc. 0.68%505.393.8%$207.76m
ZBHZimmer Biomet Holdings, Inc. -0.32%122.151.7%$196.25m
PKIPerkinElmer, Inc. (United States) -1.21%172.762.4%$178.71m

Company Profile

LumiraDX Ltd. engages in the provision of next-generation POC diagnostic company, which focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. The firm developed and launched the platform, which is an integrated system comprised of a small, versatile POC instrument, or Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, David Scott, and Jerry McAleer in 2014 and is headquartered in London, the United Kingdom.